MENU
+Compare
LMAT
Stock ticker: NASDAQ
AS OF
May 13 closing price
Price
$83.28
Change
+$0.82 (+0.99%)
Capitalization
1.48B

LMAT LeMaitre Vascular Forecast, Technical & Fundamental Analysis

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease... Show more

LMAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for LMAT with price predictions
May 12, 2025

LMAT in upward trend: price may jump up because it broke its lower Bollinger Band on May 02, 2025

LMAT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 27 cases where LMAT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LMAT advanced for three days, in of 331 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 299 cases where LMAT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for LMAT moved out of overbought territory on April 30, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on May 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on LMAT as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for LMAT turned negative on May 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

LMAT moved below its 50-day moving average on May 02, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for LMAT crossed bearishly below the 50-day moving average on May 12, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The 50-day moving average for LMAT moved below the 200-day moving average on April 08, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LMAT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.943) is normal, around the industry mean (24.179). P/E Ratio (49.194) is within average values for comparable stocks, (79.397). Projected Growth (PEG Ratio) (2.819) is also within normal values, averaging (5.667). Dividend Yield (0.009) settles around the average of (0.018) among similar stocks. P/S Ratio (7.639) is also within normal values, averaging (42.574).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LMAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
LMAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

LMAT is expected to report earnings to rise 21.58% to 58 cents per share on July 24

LeMaitre Vascular LMAT Stock Earnings Reports
Q2'25
Est.
$0.58
Q1'25
Missed
by $0.03
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.05
Q2'24
Beat
by $0.05
The last earnings report on May 01 showed earnings per share of 47 cents, missing the estimate of 50 cents. With 195.61K shares outstanding, the current market capitalization sits at 1.48B.
A.I.Advisor
published Dividends

LMAT is expected to pay dividends on May 29, 2025

LeMaitre Vascular LMAT Stock Dividends
A dividend of $0.20 per share will be paid with a record date of May 29, 2025, and an ex-dividend date of May 15, 2025. The last dividend of $0.20 was paid on March 27. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of vascular devices for vascular surgeons

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
63 Second Avenue
Phone
+1 781 221-2266
Employees
630
Web
https://www.lemaitre.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA318.3820.12
+6.75%
Tesla
AAPL210.7912.52
+6.31%
Apple
SPY582.9918.65
+3.30%
SPDR® S&P 500® ETF
GME28.050.51
+1.85%
GameStop Corp
BTC.X102812.950000-1293.406200
-1.24%
Bitcoin cryptocurrency

LMAT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LMAT has been loosely correlated with SYK. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if LMAT jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LMAT
1D Price
Change %
LMAT100%
+2.74%
SYK - LMAT
45%
Loosely correlated
+1.88%
ITGR - LMAT
42%
Loosely correlated
+1.91%
PDEX - LMAT
38%
Loosely correlated
-9.08%
UFPT - LMAT
36%
Loosely correlated
+3.27%
CDNA - LMAT
35%
Loosely correlated
+6.51%
More